Literature DB >> 28402467

Natural History and Risk Factor of Recurrent Hemorrhage in Hemorrhagic Adult Moyamoya Disease.

Kang Min Kim1, Jeong Eun Kim2, Won-Sang Cho2, Hyun-Seung Kang2, Young-Je Son2, Moon Hee Han2,3, Chang Wan Oh.   

Abstract

BACKGROUND: Recurrent hemorrhage is a serious neurosurgical problem in adult moyamoya disease (MMD) patients.
OBJECTIVE: To find the natural history and risk factors of recurrent hemorrhage in cases of adult hemorrhagic MMD.
METHODS: One hundred seventy-six adult MMD patients presenting with hemorrhage were enrolled. Patients' medical records and radiological images were retrospectively reviewed. Clinical and radiological features of recurrent hemorrhage, and related risk factors were analyzed. Poor neurological outcome was defined as a score on the modified Rankin Scale of 4 to 6. The hemisphere in which the initial hemorrhage occurred was considered as the affected one. The mean follow-up duration was 83 months.
RESULTS: The overall estimated rate of recurrent hemorrhage was 16.9%/person (95% confidence interval, 11.3%-24.8%) at 5 years and 26.3%/person (95% confidence interval, 18.5%-36.4%) at 10 years after the initial episode of hemorrhage. The affected hemisphere showed a higher recurrent hemorrhagic rate (11.7% vs 8.3%/hemisphere at 5 years, P = .09) after conservative treatment. As a result of recurrent hemorrhages, the number of patients with poor neurological outcome increased (first episode: 13.8%, second: 37.5%, third: 40.0%, fourth: 100%). The presence of intraventricular hemorrhage ( P = .05, hazard ratio = 3.32) and bilateral MMD ( P = .05, hazard ratio = 4.15) had a marginal significance for recurrent hemorrhage. Eight ischemic strokes (4.5%) including 4 postoperative infarctions were identified, and all ischemic strokes were minor stroke.
CONCLUSION: During the follow-up period, recurrent hemorrhagic events continued to increase and deteriorated the patients' neurological conditions. The presence of intraventricular hemorrhage was a significant risk factor of recurrent hemorrhage.
Copyright © 2017 by the Congress of Neurological Surgeons

Entities:  

Keywords:  Hemorrhage; Moyamoya disease; Natural history; Risk factors

Mesh:

Year:  2017        PMID: 28402467     DOI: 10.1093/neuros/nyw179

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  9 in total

Review 1.  Surgical Treatment of Adult Moyamoya Disease.

Authors:  Si Un Lee; Chang Wan Oh; O-Ki Kwon; Jae Seung Bang; Seung Pil Ban; Hyoung Soo Byoun; Tackeun Kim
Journal:  Curr Treat Options Neurol       Date:  2018-05-28       Impact factor: 3.598

2.  Surgical revascularization vs. conservative treatment for adult hemorrhagic moyamoya disease: analysis of rebleeding in 322 consecutive patients.

Authors:  Shaojie Yu; Nan Zhang; Jian Liu; Changwen Li; Sheng Qian; Yong Xu; Tao Yang; Nan Li; Minghui Zeng; Dongxue Li; Chengyu Xia
Journal:  Neurosurg Rev       Date:  2021-12-03       Impact factor: 3.042

3.  MicroRNA Expression in Circulating Leukocytes and Bioinformatic Analysis of Patients With Moyamoya Disease.

Authors:  Kaijiang Kang; Yuan Shen; Qian Zhang; Jingjing Lu; Yi Ju; Ruijun Ji; Na Li; Jianwei Wu; Bo Yang; Jinxi Lin; Xianhong Liang; Dong Zhang; Xingquan Zhao
Journal:  Front Genet       Date:  2022-05-20       Impact factor: 4.772

4.  Delayed Anastomotic Occlusion after Direct Revascularization in Adult Hemorrhagic Moyamoya Disease.

Authors:  Yu Chen; Fa Lin; De-Bin Yan; He-Ze Han; Ya-Hui Zhao; Li Ma; Yong-Gang Ma; Long Ma; Xun Ye; Rong Wang; Xiao-Lin Chen; Dong Zhang; Yuan-Li Zhao; Shuai Kang
Journal:  Brain Sci       Date:  2021-04-24

5.  Development and Validation of a Nomogram to Predict the Individual Future Stroke Risk for Adult Patients With Moyamoya Disease: A Multicenter Retrospective Cohort Study in China.

Authors:  Fei Ye; Tianzhu Wang; Haoyuan Yin; Jiaoxing Li; Haiyan Li; Tongli Guo; Xiong Zhang; Tingting Yang; Liang Jie; Xiaoxin Wu; Qi Li; Wenli Sheng
Journal:  Front Neurol       Date:  2021-05-13       Impact factor: 4.003

6.  Cardiovascular surgery experience does not significantly improve patients' response to stroke.

Authors:  Shengde Li; Li-Ying Cui; Craig Anderson; Chunpeng Gao; Chengdong Yu; Guangliang Shan; Longde Wang; Bin Peng
Journal:  Brain Behav       Date:  2019-09-12       Impact factor: 2.708

7.  Clinical and Radiological Outcomes After Revascularization of Hemorrhagic Moyamoya Disease.

Authors:  Kaijiang Kang; Jingjing Lu; Yi Ju; Ruijun Ji; Dandan Wang; Yuan Shen; Lebao Yu; Bin Gao; Dong Zhang; Xingquan Zhao
Journal:  Front Neurol       Date:  2020-05-07       Impact factor: 4.003

8.  Recurrent hemorrhage risk associated with medial target medullary artery anastomosis from the periventricular collateral vessel in adult patients with moyamoya disease.

Authors:  Jian Wang; Liming Tang; Yongbo Yang; Qingrong Zhang; Xia Lu; Qun Liang; Yi Wang; Yichao Zhu; Shijie Na; Fang Liu
Journal:  BMC Neurol       Date:  2021-03-06       Impact factor: 2.474

9.  Digital subtraction angiographic characteristics of progression of moyamoya disease 6 months prior to surgical revascularisation.

Authors:  Peicong Ge; Qian Zhang; Xun Ye; Xingju Liu; Xiaofeng Deng; Jia Wang; Rong Wang; Yan Zhang; Dong Zhang; Ji Zong Zhao
Journal:  Stroke Vasc Neurol       Date:  2020-02-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.